Skip to main content

Deciphera Pharmaceuticals, Inc.

DCPHDelisted Jun 11, 2024
Industry
Pharmaceutical Preparations
SEC CIK
0001654151

Deciphera Pharmaceuticals, Inc. was delisted on Jun 11, 2024; its insiders filed their last Form 4 on Jun 11, 2024; 177 institutions reported holding it in 13F filings for Q1 2024, worth $943.7M in total; no superinvestor held it.

Q3 2021 vs. Q2 2021

How the institutions holding Deciphera Pharmaceuticals, Inc. changed between Q2 2021 and Q3 2021.

All holders in Q3 2021All holders in Q2 2021

13F holders of DCPH: Q2 2021 compared with Q3 2021
MeasureQ2 2021Of which not filed for Q3 2021Q3 2021Change
Holders1471162+16
Shares43.5M751.1K42.7M−8.34K (0.0%)
Value$1.58B$27.5M$1.45B−$99.0M (−6.4%)

1 institution that held it in Q2 2021 haven't filed for Q3 2021 yet. Not filing isn't selling, so the changes leave them out.

New holders (28)

Institutions that held Deciphera Pharmaceuticals, Inc. at the end of Q3 2021 but not at the end of Q2 2021.

Institutions new to DCPH in Q3 2021
InstitutionSharesValue% of portfolio
Pictet Asset Management SA751,098$25.5M0.03%
Eventide Asset Management, LLC400,000$13.6M0.18%
PFM Health Sciences, LP143,297$4.87M0.16%
Sectoral Asset Management Inc141,500$4.81M0.40%
Fred Alger Management, LLC103,148$3.50M0.01%
Adage Capital Partners GP, L.L.C.100,000$3.40M0.01%
Gsa Capital Partners LLP60,550$2.06M0.21%
LMR Partners LLP51,335$1.74M0.02%
Pura Vida Investments, LLC50,000$1.70M0.13%
Renaissance Technologies LLC34,800$1.18M0.00%
Jane Street Group, LLC23,753$808.0K0.00%
HRT Financial LP19,628$666.0K0.00%
Ergoteles LLC13,768$468.0K0.02%
Stanley-Laman Group, Ltd.12,349$420.0K0.05%
Algert Global LLC11,203$381.0K0.05%
Winton Group Ltd9,913$337.0K0.02%
Teacher Retirement System of Texas6,496$221.0K0.00%
SG3 Management, LLC6,000$204.0K0.07%
Walleye Capital LLC5,891$200.0K0.01%
Point72 Hong Kong Ltd1,553$53.0K0.00%
Cowen and Company, LLC1,292$44.0K0.00%
Signaturefd, LLC683$23.0K0.00%
Koshinski Asset Management, Inc.100$3.40K0.00%
TCI Wealth Advisors, Inc.90$3.00K0.00%
The PNC Financial Services Group, Inc.15$1.00K0.00%
Quadrant Capital Group LLC29$1.00K0.00%
Berman Capital Advisors, LLC38$1.00K0.00%
Meridian Wealth Partners, LLC5$00.00%

Sold out (12)

Institutions that held Deciphera Pharmaceuticals, Inc. at the end of Q2 2021 and filed for Q3 2021 without it.

Institutions that sold out of DCPH in Q3 2021
InstitutionShares, Q2 2021Value, Q2 2021
Consonance Capital Management LP388,222$14.2M
Tekla Capital Management LLC307,703$11.3M
Alyeska Investment Group, L.P.142,932$5.23M
AlphaCrest Capital Management LLC44,600$1.63M
Bank of Montreal39,102$1.44M
Blueshift Asset Management, LLC16,798$615.0K
DekaBank Deutsche Girozentrale16,400$591.0K
Emerald Advisers, LLC8,865$325.0K
Walleye Trading LLC2,722$100.0K
Lazard Asset Management LLC1,739$63.0K
Leonteq Securities AG631$23.1K
Lindbrook Capital, LLC106$4.00K

Not filed for Q3 2021 yet (1)

Institutions that held Deciphera Pharmaceuticals, Inc. at the end of Q2 2021 and haven't filed a 13F for Q3 2021. Not filing isn't selling, so they aren't counted as sold out.

Institutions holding DCPH in Q2 2021 that haven't filed for Q3 2021
InstitutionShares, Q2 2021Value, Q2 2021
Pictet Asset Management Ltd751,098$27.5M